Zynerba Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
The company reported financial results for the second quarter ended June 30, 2019.
Read More
Select Page
Posted by Invest In Weed | Aug 6, 2019
The company reported financial results for the second quarter ended June 30, 2019.
Read MorePosted by Invest In Weed | Aug 2, 2019
Farmers now have another crop option and potential revenue stream that could offset years of declining commodity prices.
Read MorePosted by Invest In Weed | Aug 1, 2019
The value of the Order is expected to generate proceeds from the sale of cannabis exceeding $1.0 million.
Read MorePosted by Invest In Weed | Jul 30, 2019
AXIM® Wellness division will address the high demand for cannabinoid-based solutions worldwide through a series of patented nutraceutical products.
Read MorePosted by Invest In Weed | Jul 26, 2019
Farmers can now grow and sell hemp-based products at close to $40 a pound compared to their previous crops which sold at close to $1 a pound, in the case of kale.
Read MoreGet stock alerts, news & related alerts straight to your inbox!